Johnson & Johnson

Early data released form phase one and two trials of Johnson & Johnson’s COVID-19 vaccine show that it appears to be safe and generates an immune response

The scientific leader of the U.S. vaccine effort will stay in the role for 30 days, but won’t be chief advisor as of Inauguration Day, sources say.

A one-shot vaccine could significantly improve our ability to fight the virus — and we may have one soon.

CNBC’s Jim Cramer called the recently approved coronavirus stimulus package “the $900 billion bridge” to a widely available Covid vaccine.

“This has been a challenging process because there have been multiple conversations happening as recently as November,” Dr. Scott Gottlieb told CNBC.

Bill Gates has predicted there could be as many as half a dozen Covid-19 vaccines approved and ready for distribution by the first quarter next year.

“It reminded me of getting the flu shot. It was virtually painless, the vaccine itself,” Republican Sen. Steve Daines of Montana told CNBC.

Vaccine news this week has failed to give the health-care sector a lift. Mark Newton of Newton Advisors shares three charts that put the move into context.

“The reason I participated in this trial was because I think the vaccines are so important,” Ohio Republican Sen. Rob Portman told CNBC on Tuesday.

U.S. stocks jumped, nearing a record 30,000 on the Dow, after Moderna said preliminary trial data showed its coronavirus vaccine is more than 94% effective.

Emirates said it was working with Pfizer on the complex logistics of transporting its vaccine to the world.

AstraZeneca and Johnson & Johnson announced Friday that they would resume their phase 3 clinical trials on COVID-19 vaccine candidates in the U.S, NBC News reports.

A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot. The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events “are an expected part of any clinical study, especially large studies,” but that its physicians...

The company said it had paused clinical trials following an “unexplained” patient illness.

A fourth COVID-19 vaccine candidate has gone into the final stage of clinical trials in the U.S., with Johnson & Johnson announcing the start of its Phase 3 trial Wednesday, NBC News reports.

Several major players in the global race for a coronavirus vaccine took steps to move their research forward this week. Pharmaceutical companies developing potential vaccines, including Moderna and Johnson & Johnson, announced start times for various phases of clinical trials in humans. In addition, a U.S. Army lab announced the selection of a lead vaccine candidate, along with two...

One-hundred years after the invention of the Band-Aid, Johnson & Johnson will launch a new line of the bandages in a range of Black and brown skin tones. “We hear you. We see you. We’re listening to you,” the Band-Aid brand said in an Instagram post on Thursday that cited the need to take action for “tangible change for...

Johnson & Johnson said Tuesday that it is discontinuing its talc-based baby powder in the United States and Canada as the company faced mounting lawsuits that said it caused cancer and demand fell.

A San Diego Superior Court Judge ordered Johnson & Johnson to pay $343.99 million for hiding the dangers and risks of its surgical mesh product for women.

An Oklahoma judge who last summer ordered consumer products giant Johnson & Johnson to pay $572 million to help address the state’s opioid crisis on Friday reduced that amount in his final order in the case by $107 million because of his miscalculation. District Judge Thad Balkman’s latest order directs the company to pay the state $465 million. In it,...